-
1
-
-
0027394324
-
Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells
-
Stillwell, W., Ehringer, W., and Jenski, L. J., Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells. Lipids, 28, 103-108 (1993).
-
(1993)
Lipids
, vol.28
, pp. 103-108
-
-
Stillwell, W.1
Ehringer, W.2
Jenski, L.J.3
-
2
-
-
0023941665
-
Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation
-
Begin, M. E., Ellis, G., and Horrobin, D. F., Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J. Natl. Cancer Inst., 80, 188-194 (1988).
-
(1988)
J. Natl. Cancer Inst.
, vol.80
, pp. 188-194
-
-
Begin, M.E.1
Ellis, G.2
Horrobin, D.F.3
-
3
-
-
0031945478
-
Effects of polyunsaturated fatty acids and their n-6 hydroperoxides on growth of five malignant cell lines and the significance of culture media
-
Nöding, R., Schonberg, S. A., Krokan, H. E., and Bjerve, K. S., Effects of polyunsaturated fatty acids and their n-6 hydroperoxides on growth of five malignant cell lines and the significance of culture media. Lipids, 33, 285-292 (1998).
-
(1998)
Lipids
, vol.33
, pp. 285-292
-
-
Nöding, R.1
Schonberg, S.A.2
Krokan, H.E.3
Bjerve, K.S.4
-
4
-
-
0031973280
-
Can tumor cell drug resistance be reversed by essential fatty acids and their metabolite?
-
Das, U. N., Madhavi, N., Kumar, G. S., Padma, M., and Sangeetha, P., Can tumor cell drug resistance be reversed by essential fatty acids and their metabolite? Prostaglandins, Leukotrienes and Essential Fatty Acids, 58, 39-54 (1998).
-
(1998)
Prostaglandins, Leukotrienes and Essential Fatty Acids
, vol.58
, pp. 39-54
-
-
Das, U.N.1
Madhavi, N.2
Kumar, G.S.3
Padma, M.4
Sangeetha, P.5
-
5
-
-
0032498548
-
Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231
-
Germain, E., Chajes, V., Cognault, S., Lhuillery, C., and Bougnoux, P., Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231. Int. J. Cancer, 75, 578-583 (1998).
-
(1998)
Int. J. Cancer
, vol.75
, pp. 578-583
-
-
Germain, E.1
Chajes, V.2
Cognault, S.3
Lhuillery, C.4
Bougnoux, P.5
-
6
-
-
0034818671
-
Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with Falciparum malaria
-
Binh, T. Q., Ilett, K. F., Davis, T. M., Hung, N. C., Powell, S. M., Thu, L. T., Thien, H. V., Phuong, H. L., and Phuong, Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with Falciparum malaria. British J. Clin. Pharmacol., 51, 541-546 (2001).
-
(2001)
British J. Clin. Pharmacol.
, vol.51
, pp. 541-546
-
-
Binh, T.Q.1
Ilett, K.F.2
Davis, T.M.3
Hung, N.C.4
Powell, S.M.5
Thu, L.T.6
Thien, H.V.7
Phuong, H.L.8
Phuong9
-
7
-
-
0032589960
-
Lipid peroxides, nitric oxide and essential fatty acids in patients with Plasmodium falciparum malaria
-
Kumar, C. A., and Das, U. N., Lipid peroxides, nitric oxide and essential fatty acids in patients with Plasmodium falciparum malaria. Prostaglandins, Leukotrienes and Biochemistry, 61, 255-258 (1999).
-
(1999)
Prostaglandins, Leukotrienes and Biochemistry
, vol.61
, pp. 255-258
-
-
Kumar, C.A.1
Das, U.N.2
-
8
-
-
0027230340
-
Antimalarial effects of purified and α-tochopherol-fortified n-3 polyunsaturated fatty acids
-
Fujikawa, M., Kamitani, T., Tunru, I., Yamazaki, K., and Hamazaki, T., Antimalarial effects of purified and α-tochopherol-fortified n-3 polyunsaturated fatty acids. J. Nutr. Biochem., 4, 153-157 (1993).
-
(1993)
J. Nutr. Biochem.
, vol.4
, pp. 153-157
-
-
Fujikawa, M.1
Kamitani, T.2
Tunru, I.3
Yamazaki, K.4
Hamazaki, T.5
-
9
-
-
0026517259
-
Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei
-
Kumaratilake, L. M., Robinson, B. S., Ferrante, A., and Poulos, A., Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. J. Clinical. Investigation, 89, 961-967 (1992).
-
(1992)
J. Clinical. Investigation
, vol.89
, pp. 961-967
-
-
Kumaratilake, L.M.1
Robinson, B.S.2
Ferrante, A.3
Poulos, A.4
-
10
-
-
0036256134
-
Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhihibits cell proliferation
-
Zerouga, M., Stillwell, W., and Jenski, L. J., Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhihibits cell proliferation. Anti-Cancer Drugs, 13, 301-311 (2002).
-
(2002)
Anti-Cancer Drugs
, vol.13
, pp. 301-311
-
-
Zerouga, M.1
Stillwell, W.2
Jenski, L.J.3
-
11
-
-
0033566212
-
Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7-pentoxocanes and 1,2,4,5-tetroxanes
-
Kim, H.-S., Shibata, Y., Wataya, Y., Tsuchiya, K., Masuyama, A., and Nojima, M., Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7-pentoxocanes and 1,2,4,5-tetroxanes. J. Med. Chem., 42, 2604-2609 (1999).
-
(1999)
J. Med. Chem.
, vol.42
, pp. 2604-2609
-
-
Kim, H.-S.1
Shibata, Y.2
Wataya, Y.3
Tsuchiya, K.4
Masuyama, A.5
Nojima, M.6
|